Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Solid-phase PCR (Polymerase Chain Reaction) kit for gene detection of precision drug utilization of cardiovascular and cerebrovascular diseases

A technology for cardiovascular and cerebrovascular diseases and precise drug use, applied in the field of PCR application, can solve the problems of hindering the expansion of thrombus and no thrombolytic effect, and achieve the effects of low cost of reagent consumables, improved detection sensitivity and specificity, and simple operation.

Inactive Publication Date: 2018-05-25
安徽安龙基因科技有限公司
View PDF3 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Warfarin is a dicoumarin anticoagulant that can hinder the expansion of thrombus, but has no thrombolytic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid-phase PCR (Polymerase Chain Reaction) kit for gene detection of precision drug utilization of cardiovascular and cerebrovascular diseases
  • Solid-phase PCR (Polymerase Chain Reaction) kit for gene detection of precision drug utilization of cardiovascular and cerebrovascular diseases
  • Solid-phase PCR (Polymerase Chain Reaction) kit for gene detection of precision drug utilization of cardiovascular and cerebrovascular diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 11

[0023] Example 1 Composition of solid-phase PCR detection kit for precision medicine of 13 kinds of cardiovascular and cerebrovascular diseases

[0024]The kit consists of a PCR reaction mixture and 12 strip tubes or a 96-well PCR reaction plate, in which the PCR reaction mixture is 5×PCRBuffer (Tris-HCl pH8.5 100mM, KCl 500nM, MgCl 2 15nM, dNTPs10mM), Mg 2+ , 20 pairs of primers and hot start DNA polymerase.

[0025] The kit is to seal a layer of paraffin wax mixture on the surface of the above PCR reaction mixture, and the paraffin wax mixture is formed by mixing solid paraffin and liquid paraffin at a ratio of 1:8 (W / V).

[0026] The reaction system (25ul) of the kit is: PCR reaction solution 23ul, template 2ul.

Embodiment 2

[0027] Operation and result determination of embodiment 2 kit

[0028] 1. Genomic DNA extraction

[0029] The exfoliated cells on the inner surface of the human oral cavity were extracted with oral swabs, and DNA was extracted with an oral swab genomic DNA extraction kit (Tiangen Biochemical Technology, item number: DP322) according to the kit instructions.

[0030] 2. Preparation of reaction system

[0031] Take the 12-tube strip tube or 96-well PCR reaction plate of the Solid-Phase PCR Reaction Kit for Genetic Detection of Precise Medicine for Cardiovascular and Cerebrovascular Diseases, and add 2ul of the extracted DNA.

[0032] 3. PCR amplification

[0033] Put the PCR tube into an ordinary PCR machine and perform PCR amplification according to the instructions recommended.

[0034] 4. Analysis of PCR products by 1.0% agarose gel electrophoresis

[0035] 5. Interpretation of results

[0036] The result interpretation standard of this kit is as follows Table 1

[0037...

Embodiment 3

[0038] Example 3 Interpretation of sequencing results and medication guidance

[0039] Using the DNA extracted from oral swabs of patients with cardiovascular and cerebrovascular diseases in Example 1 as a template, after amplification with the above kit, the following sequencing results were obtained, and the corresponding medication instructions were given as follows according to the sequencing results:

[0040]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a solid-phase PCR (Polymerase Chain Reaction) kit for gene detection of precision drug utilization of cardiovascular and cerebrovascular diseases. The solid-phase PCR kit comprises a PCR solution mixed solution and 12 parallel-arrayed pipes or a 96-pore PCR plate, wherein the PCR solution mixed solution is prepared from a primer set, hot-start DNA (Deoxyribonucleic Acid) polymerase and a PCR buffering solution. Compared with the prior art, the solid-phase PCR kit disclosed by the invention has the advantages that 1) the operation is simple and convenient; only a nucleicacid template needs to be added into a solid-phase PCR plate and then the solid-phase PCR plate can be directly put on a machine for amplification; the solid-phase PCR kit is simple to operate and good in clinical detection specificity; the sensitivity is equivalent to quantitative PCR, and the kit has relatively strong clinical application and popularization value; 2) the sensitivity is high andthe specificity is strong; the solid-phase PCR kit disclosed by the invention adopts the hot-start DNA polymerase so that non-specific amplification is avoided, and the sensitivity and the specificity of the detection are improved; 3) detection sites are complete and the kit is suitable for safety drug utilization guidance of the cardiovascular and cerebrovascular diseases. In conclusion, a specific primer sequence is adopted and the reliability of a detection result is ensured; a detection method has the advantages of simplicity in operation, time saving and labor saving, large detection flux and low cost of reagent consumable items.

Description

technical field [0001] The invention relates to the technical field of PCR application, in particular to a solid-phase PCR kit for gene detection of precise medication for cardiovascular and cerebrovascular diseases. Background technique [0002] In my country, 3.5 million people die from cardiovascular and cerebrovascular diseases every year, and an average of 1 person dies from cardiovascular and cerebrovascular diseases every 10 seconds. It can be seen that the prevention and treatment of cardiovascular and cerebrovascular diseases has become the top priority of safeguarding human health. Because each person's genetic reasons, gender, height and weight, environment, lifestyle, etc. are not the same, resulting in large differences in treatment effects. Now clinicians follow the treatment guidelines in principle, but the guidelines are aimed at groups, and there are great individual differences. Precision medicine formulates individualized treatment plans through genetic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6883
CPCC12Q1/6883C12Q2600/106C12Q2600/156
Inventor 韦玉军李航刘琳琳苏军
Owner 安徽安龙基因科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com